Data / Drug companies / PureTek Corporation
PureTek Corporation: 179 products in the FDA NDC directory, labeler code 59088
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
PureTek Corporation (labeler code 59088) lists 179 products in the FDA National Drug Code Directory, covering 75 finished drugs by generic name. By type: 128 prescription drugs, 51 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on October 6, 2026.
The request: Watch PureTek Corporation (FDA labeler code 59088): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 59088
- Products in commercial distribution
- 179
- Packages
- 188
- Finished drugs by generic name
- 75
- Prescription products
- 128
- Over the counter products
- 51
- Flagged as original packager
- 161 of 161 products that carry the flag
- Started marketing in the last 12 months
- 16
- Earliest marketing start
- June 1, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 121 | 67.6% |
| Over the counter monograph drugs | 50 | 27.9% |
| Generic drugs (ANDA) | 8 | 4.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 128 | 71.5% |
| Over the counter drugs | 51 | 28.5% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 7 | 330 |
| Lidocaine hcl and hydrocortisone acetate | 7 | 1 |
| Lidocaine hydrochloride | 7 | 134 |
| Folic acid, vitamin d3 | 6 | 1 |
| Lidocaine 5% | 6 | 23 |
| Tolnaftate | 4 | 99 |
| Lidocaine | 4 | 216 |
| Lidocaine hcl | 3 | 48 |
| Methyl salicylate | 3 | 24 |
| Dimethicone | 3 | 69 |
| Clotrimazole | 3 | 98 |
| Miconazole nitrate | 3 | 101 |
| Capsaicin | 3 | 66 |
| Menthol, methyl salicylate | 2 | 36 |
| Capsaicin 0.025% | 2 | 4 |
| Diclofenac sodium, isopropyl alcohol | 2 | 1 |
| Diclofenac sodium, kinesiology tape | 2 | 1 |
| Miconazole nitrate 2% antifungal | 2 | 2 |
| L-ascorbic acid | 2 | 1 |
| Camphor, menthol | 2 | 35 |
| Urea | 2 | 17 |
| Tolnaftate, hydrocortisone | 2 | 1 |
| Lidocaine hci 3.88% | 2 | 1 |
| Zinc oxide | 2 | 595 |
| Hydrocortisone 2% | 2 | 2 |
| Benzalkonium chloride | 2 | 271 |
| Diclofenac sodium, capsaicin | 2 | 1 |
| Alcohol | 2 | 293 |
| Lidocaine hcl - hydrocortisone acetate | 2 | 1 |
| Urea 20% | 2 | 1 |
| Diclofenac potassium 25 mg | 1 | 1 |
| Lidocaine hcl 5 % , hydrocortisone acetate 1% | 1 | 1 |
| Gabapentin | 1 | 91 |
| Diclofenac sodium, camphor and menthol | 1 | 1 |
| Salicylic acid 10% | 1 | 1 |
| Lidocaine hcl, hydrocortisone acetate | 1 | 1 |
| Lidocaine, isopropyl alcohol | 1 | 1 |
| Ibuprofen | 1 | 190 |
| Lidocaine, dimethicone | 1 | 1 |
| Camphor,menthol, methyl salicylate | 1 | 2 |
| Hydrocortisone | 1 | 171 |
| Lidocaine hcl 2% | 1 | 1 |
| Capsaicin 0.1% | 1 | 4 |
| Miconazole nitrate and tolnaftate | 1 | 1 |
| Lidocaine hcl, diclofenac sodium | 1 | 1 |
| Clotrimazole and betamethasone dipropionate, zinc oxide | 1 | 1 |
| Sumatriptan succinate, camphor, menthol | 1 | 1 |
| Methocarbamol | 1 | 67 |
| Clotrimazole 1% | 1 | 11 |
| Camphor 4% plus menthol 10% | 1 | 1 |
| Fluocinonide | 1 | 25 |
| Menthol, capsaicin | 1 | 8 |
| Methyl salicylate 10% | 1 | 3 |
| Dimethicone, allantoin | 1 | 1 |
| Lidocaine hcl 4%, menthol 1% | 1 | 5 |
| Capsaicin 0.035% cream | 1 | 1 |
| Lidocaine hcl 5% | 1 | 1 |
| Lidocaine hcl 4.12 % | 1 | 1 |
| Fluocinonide, dimethicone | 1 | 1 |
| Lidocaine hcl, benzalkonium chloride | 1 | 3 |
| Hyoscyamine sulfate 0.125 mg | 1 | 1 |
| Folate, vitamin d3 | 1 | 2 |
| Lidocaine hci | 1 | 7 |
| Lidocaine hydrochloride, menthol | 1 | 14 |
| Chlorhexidine gluconate surgical combo kit | 1 | 1 |
| Naproxen , capsaicin | 1 | 1 |
| Camphor, menthol, methyl salicylate | 1 | 36 |
| Urea, salicylic acid | 1 | 1 |
| Capsaicin 0.05% | 1 | 1 |
| Urea 10% | 1 | 2 |
| Sumatriptan succinate, ondansetron | 1 | 1 |
| Lidocaine hcl 3% | 1 | 1 |
| Mupirocin ointment | 1 | 2 |
| Avobenzone, octinoxate, octisalate, titanium dioxide | 1 | 1 |
| Triamcinolone acetonide | 1 | 77 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 47 | 26.3% |
| Tablet | 38 | 21.2% |
| Kit | 29 | 16.2% |
| Gel | 24 | 13.4% |
| Liquid | 12 | 6.7% |
| Tablet, chewable | 7 | 3.9% |
| Patch | 7 | 3.9% |
| Capsule | 4 | 2.2% |
| Spray | 4 | 2.2% |
| Powder | 2 | 1.1% |
| Paste | 2 | 1.1% |
| Capsule, liquid filled | 1 | 0.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Urea 20% | 59088-258 | Cream | Other unapproved drugs | October 6, 2026 |
| Uracin 10% | 59088-256 | Cream | Other unapproved drugs | September 10, 2026 |
| Salicylic Acid 6% Gel | 59088-216 | Gel | Other unapproved drugs | September 10, 2026 |
| PNV Prenatol | 59088-078 | Tablet | Other unapproved drugs | August 21, 2026 |
| Penetral Roll-on | 59088-329 | Gel | Over the counter monograph drugs | July 14, 2026 |
| Boostervite | 59088-022 | Tablet | Other unapproved drugs | June 19, 2026 |
| Lasolex AL | 59088-238 | Liquid | Over the counter monograph drugs | June 11, 2026 |
| Lasolex AC | 59088-239 | Cream | Over the counter monograph drugs | June 3, 2026 |
| Vitalux | 59088-139 | Tablet | Other unapproved drugs | June 3, 2026 |
| Digenyx | 59088-150 | Tablet | Other unapproved drugs | May 13, 2026 |
| Diclofenac Potassium | 59088-131 | Capsule, liquid filled | Generic drugs (ANDA) | April 10, 2026 |
| Capsaicin 0.1% Cream | 59088-242 | Cream | Over the counter monograph drugs | April 3, 2026 |
| Lasolex Liquid Solution | 59088-251 | Solution | Over the counter monograph drugs | March 24, 2026 |
| Salicylic Acid 6% Gel | 59088-261 | Gel | Other unapproved drugs | February 19, 2026 |
| Uracin 20% | 59088-257 | Cream | Other unapproved drugs | February 2, 2026 |
| Lasolex AG | 59088-207 | Gel | Over the counter monograph drugs | December 3, 2025 |
| Lidocaine 5% Gel | 59088-247 | Gel | Other unapproved drugs | September 19, 2025 |
| Diclolidol Kit | 59088-806 | Kit | Other unapproved drugs | September 9, 2025 |
| Lidochill(TM) Gel | 59088-240 | Gel | Over the counter monograph drugs | September 8, 2025 |
| Camphor 4% Plus Menthol 10% | 59088-259 | Gel | Over the counter monograph drugs | August 20, 2025 |
| Capsaicin 0.035% Cream | 59088-246 | Cream | Over the counter monograph drugs | August 20, 2025 |
| Lidocaine 3% | 59088-241 | Cream | Over the counter monograph drugs | August 12, 2025 |
| Lidoease 2% | 59088-221 | Gel | Over the counter monograph drugs | August 6, 2025 |
| Flotrex | 59088-020 | Tablet, chewable | Other unapproved drugs | July 10, 2025 |
| Exemax Cream | 59088-212 | Cream | Over the counter monograph drugs | July 2, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.